Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
about
Albendazole versus praziquantel in the treatment of neurocysticercosis: a meta-analysis of comparative trialsAnthelmintics for people with neurocysticercosisAnthelmintics for people with neurocysticercosisNeurocysticercosis: a reviewManaging neurocysticercosis: challenges and solutionsDrug therapy for solitary cysticercus granuloma: a systematic review and meta-analysis.Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and reviewFrom seizures to epilepsy and its substrates: neurocysticercosisA diagnostic and therapeutic scheme for a solitary cysticercus granulomaMixed cestode infection: an incidental association in an immunocompetent person.Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease.Radiological evolution of porcine neurocysticercosis after combined antiparasitic treatment with praziquantel and albendazole.Treatment of neurocysticercosis: current status and future research needsMedical management of neurocysticercosis.Intraventricular neurocysticercosis: a review of current status and management issues.Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.Neurocysticercosis case with tuberculoma-like epithelioid granuloma strongly suspected by serology and confirmed by mitochondrial DNAPharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.Albendazole and Corticosteroids for the Treatment of Solitary Cysticercus Granuloma: A Network Meta-analysis.Diagnosis and treatment of neurocysticercosis.Efficacy of diverse antiparasitic treatments for cysticercosis in the pig model.In vitro analysis of albendazole sulfoxide enantiomers shows that (+)-(R)-albendazole sulfoxide is the active enantiomer against Taenia soliumNeurocysticercosis: current knowledge and advances.Advances in the diagnosis and management of neurocysticercosis.Bacterial, fungal, parasitic, and viral myositisCysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.Neurocysticercosis: Five new things.Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazoleDo helminths cause epilepsy?Neurocysticercosis in the United StatesInfectious causes of seizures and epilepsy in the developing world.Cysticercosis of the central nervous system: how should it be managed?Parasitic infections and myositis.Diagnostic criteria for neurocysticercosis, revisited.Current status and future perspectives on the medical treatment of neurocysticercosis.Neurocysticercosis: A disease of neglect.Clinical management of neurocysticercosis.Parasitic diseases in travelers: a focus on therapy.The relationship between neurocysticercosis and epilepsy: an endless debate.
P2860
Q21092309-4B25E871-B76A-488A-8C10-84B67C7D4705Q24236593-86A36E68-AD21-449C-978C-662B2F635DE6Q24240646-BBD2DAE0-6A84-4D67-BDF6-AE422CBDA37FQ24606075-B62227AB-A753-4FB8-9E5A-ADDFDAF35055Q26777315-3DA8247E-8400-45E5-91F4-F36CD14FF9D4Q26827411-35DB461B-6F37-40DE-ACA2-ADA4C2AA7E62Q27015925-D048656C-3913-40A7-9B2F-4F237D462039Q27028097-B5AEBAC3-1B0D-4931-B2AB-57FB5A119F96Q28476683-BC8237F1-E0A9-4293-999F-427A4A068132Q30404247-B6374878-1FA7-46C5-8CDD-5D91143DD736Q33536833-0A2E4574-6D35-4F0B-B777-7E52DBF7CA96Q33776074-8AB569B3-BCF7-4BEB-9D2B-4138380AC0B9Q33797550-AD25BB5B-C339-4549-A661-7F46F937A78EQ34071278-F09FA2EC-5AB3-4963-9D82-7BB19DDFA6AAQ34074147-78FB0C90-B8AF-4B61-9664-143330333D04Q34101071-122EBA4F-6EC6-4597-8089-573A76A1FB43Q34150372-C5B2F670-8C63-4477-AC1F-92E0784D7BA2Q35113771-8B3954AC-DFEC-4129-A294-CC6A99D2D6FFQ35120602-16FB8F7F-32B4-4A13-9005-85BAE9182BE8Q35915625-74F6FB14-6305-4971-A523-CC5FA99FA21BQ35953198-1E32AF6D-F44D-4965-9C54-AFE2B2AB6B94Q36149637-598AEFE1-0F4F-48BB-BC19-8FD42ABCDDABQ36558405-D3111C81-0BE5-4CE4-8091-9722710A4D20Q36639094-0DE1DD7F-4AB9-4E5E-8E85-238D8BA5AE8CQ36688967-1D8CC698-48FC-4239-A475-3AA74CA98D93Q36803883-52E543AB-FCEF-443A-9EFF-50C005D4E24EQ36915099-1748ED8D-B04E-4175-8EB8-B6B1A9001D4FQ37040137-360AECCC-0622-477B-8B61-94D82C52AA56Q37471097-C9AC8112-D724-4E3A-890F-52A5103FA67BQ37613778-B4136DC0-6B4F-4678-9C37-D1918778E0C8Q37733225-0C0C1F76-498B-4DCA-AE55-772293368BF9Q37868785-2777F70E-70B8-4173-8210-CB2F4C7C8981Q37905499-DF014D71-9CFC-4559-8DB8-20FA57213AF7Q37924643-92CD05AB-FAF1-4E28-B509-CBC1252E55F8Q38069636-12A05BD9-2EF9-4FB4-9062-6072327D77F1Q38069637-B0C1004C-AB5F-4E3F-AAEC-995F3373EBB0Q38182595-2EDEAADF-B4AC-4934-9E7D-4BBA2C546932Q38189498-9E3948C8-41C1-46E9-9508-7DF886E39505Q38192001-564BA544-A473-4D06-BDF2-CAC86F8381E0Q38215122-1D286126-2E8C-4ACD-AEFD-FA737BE73017
P2860
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@ast
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@en
type
label
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@ast
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@en
prefLabel
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@ast
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@en
P2093
P1476
Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
@en
P2093
Christopher S Coffey
Héctor H García
Oscar H Del Brutto
P356
10.7326/0003-4819-145-1-200607040-00009
P407
P577
2006-07-01T00:00:00Z